{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:16:41Z","timestamp":1788671801025,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100023015","name":"Advanced Research Projects Agency for Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.virol.2026.111043","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:44:23Z","timestamp":1785858263000},"page":"111043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Advancing human metapneumovirus vaccine development through fusion protein stabilization"],"prefix":"10.1016","volume":"624","author":[{"given":"Ahmad Jawad","family":"Sabir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1947-7469","authenticated-orcid":false,"given":"Ted M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2026.111043_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s44162-025-00079-w","article-title":"Rising global threat of human metapneumovirus (hMPV in 2024\/2025): pathogenesis, immune dynamics, vulnerabilities in immunocompromised individuals, and lessons from past pandemics","volume":"4","author":"Adedokun","year":"2025","journal-title":"J. Rare Dis."},{"key":"10.1016\/j.virol.2026.111043_bib2","article-title":"Development and comparison of immunologic assays to detect primary RSV infections in infants","volume":"14","author":"Anderson","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2026.111043_bib3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3390\/v12060637","article-title":"Innate immune components that regulate the pathogenesis and resolution of hRSV and hMPV infections","volume":"12","author":"Andrade","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.111043_bib4","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1038\/s41467-024-50659-5","article-title":"Efficacious human metapneumovirus vaccine based on AI-guided engineering of a closed prefusion trimer","volume":"15","author":"Bakkers","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2026.111043_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/v12050542","article-title":"Cell-mediated responses to human metapneumovirus infection","volume":"12","author":"Ballegeer","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.111043_bib6","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2203326119","article-title":"Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus","volume":"119","author":"Banerjee","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.virol.2026.111043_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00342-19","article-title":"A potent neutralizing site III-specific human antibody neutralizes human metapneumovirus in vivo","volume":"93","author":"Bar-Peled","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111043_bib8","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/s41467-017-01708-9","article-title":"Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein","volume":"8","author":"Battles","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2026.111043_bib10","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1128\/JVI.00128-07","article-title":"Frequent frameshift and point mutations in the SH gene of human metapneumovirus passaged in vitro","volume":"81","author":"Biacchesi","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111043_bib9","doi-asserted-by":"crossref","first-page":"12877","DOI":"10.1128\/JVI.78.23.12877-12887.2004","article-title":"Recombinant human Metapneumovirus lacking the small hydrophobic SH and\/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate","volume":"78","author":"Biacchesi","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111043_bib11","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3201\/eid0906.030017","article-title":"Human metapneumovirus infections in hospitalized children","volume":"9","author":"Boivin","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2026.111043_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00809-24","article-title":"Small hydrophobic (SH) proteins of Pneumoviridae and Paramyxoviridae: small but mighty","volume":"98","author":"Brynes","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111043_bib13","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1128\/JVI.06706-11","article-title":"Human metapneumovirus (HMPV) binding and infection are mediated by interactions between the HMPV fusion protein and heparan sulfate","volume":"86","author":"Chang","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111043_bib14","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/pathogens4030682","article-title":"Immune response to human metapneumovirus infection: what we have learned from the mouse model","volume":"4","author":"Cheemarla","year":"2015","journal-title":"Pathogens"},{"key":"10.1016\/j.virol.2026.111043_bib15","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1002\/jmv.25713","article-title":"The role of M2-2 PDZ-binding motifs in pulmonary innate immune responses to human metapneumovirus","volume":"92","author":"Choi","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2026.111043_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/microorganisms13010073","article-title":"The silent threat of human metapneumovirus: clinical challenges and diagnostic insights from a severe pneumonia case","volume":"13","author":"Costa-Filho","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.virol.2026.111043_bib18","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1128\/JVI.00332-14","article-title":"Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model","volume":"88","author":"Cox","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111043_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005303","article-title":"Human Metapneumovirus is capable of entering cells by fusion with endosomal membranes","volume":"11","author":"Cox","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2026.111043_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/v5010192","article-title":"Breaking in: human metapneumovirus fusion and entry","volume":"5","author":"Cox","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.111043_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2007-976493","article-title":"Human metapneumovirus","volume":"28","author":"Deffrasnes","year":"2007","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.virol.2026.111043_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1557880","article-title":"Receptors and host factors: key players in human metapneumovirus infection","volume":"15","author":"Dong","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.virol.2026.111043_bib22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1086\/367901","article-title":"Human metapneumovirus infections in young and elderly adults","volume":"187","author":"Falsey","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2026.111043_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.07.007","article-title":"Differential activation of the transcription factor IRF1 underlies the distinct immune responses elicited by type I and type III interferons","volume":"51","author":"Forero","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.virol.2026.111043_bib24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3390\/v13030519","article-title":"Host components that modulate the disease caused by hMPV","volume":"13","author":"G\u00e1lvez","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.111043_bib25","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41467-024-45480-z","article-title":"A general computational design strategy for stabilizing viral class I fusion proteins","volume":"15","author":"Gonzalez","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2026.111043_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev-med-121217-094234","article-title":"Structure-based vaccine antigen design","volume":"70","author":"Graham","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.virol.2026.111043_bib27","doi-asserted-by":"crossref","first-page":"e732","DOI":"10.1016\/S2666-5247(23)00134-9","article-title":"Neutralising antibodies against human metapneumovirus","volume":"4","author":"Guo","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.virol.2026.111043_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00284-25","article-title":"Human metapneumovirus: understanding the molecular mechanisms and pathology of infection","author":"Heim","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111043_bib29","doi-asserted-by":"crossref","first-page":"8891","DOI":"10.1128\/JVI.00472-08","article-title":"Low-pH-induced membrane fusion mediated by human metapneumovirus F protein is a rare, strain-dependent phenomenon","volume":"82","author":"Herfst","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111043_bib30","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/s41467-022-28931-3","article-title":"Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins","volume":"13","author":"Hsieh","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2026.111043_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00593-21","article-title":"Structure, immunogenicity, and conformation-dependent receptor binding of the postfusion human metapneumovirus F protein","volume":"95","author":"Huang","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111043_bib32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.virol.2019.03.003","article-title":"Human metapneumovirus fusion protein triggering: increasing complexities by analysis of new HMPV fusion proteins","volume":"531","author":"Kinder","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.virol.2026.111043_bib33","article-title":"A computationally designed prefusion stabilized human metapneumovirus fusion protein vaccine Antigen elicited a potent neutralization response","volume":"13","author":"Kishko","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2026.111043_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.micinf.2009.11.002","article-title":"Human metapneumovirus M2-2 protein inhibits viral transcription and replication","volume":"12","author":"Kitagawa","year":"2010","journal-title":"Microb. Infect."},{"key":"10.1016\/j.virol.2026.111043_bib36","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.3390\/v4123551","article-title":"Human metapneumovirus antagonism of innate immune responses","volume":"4","author":"Kolli","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.111043_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4049\/jimmunol.1002589","article-title":"Human metapneumovirus glycoprotein G inhibits TLR4-dependent signaling in monocyte-derived dendritic cells","volume":"187","author":"Kolli","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2026.111043_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms12122526","article-title":"The role of inflammation in the pathogenesis of viral respiratory infections","volume":"12","author":"Kombe Kombe","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.virol.2026.111043_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanhl.2024.100679","article-title":"The global burden of human metapneumovirus-associated acute respiratory infections in older adults: a systematic review and meta-analysis","volume":"6","author":"Kulkarni","year":"2025","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.virol.2026.111043_bib39","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1038\/s41467-024-54287-x","article-title":"Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus","volume":"15","author":"Lee","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2026.111043_bib40","article-title":"Respiratory syncytial virus vaccine (mRNA)","author":"Levien","year":"2024","journal-title":"Hosp. Pharm."},{"key":"10.1016\/j.virol.2026.111043_bib41","doi-asserted-by":"crossref","first-page":"12650","DOI":"10.1128\/JVI.05485-11","article-title":"Residues of the human metapneumovirus fusion (F) protein critical for its strain-related fusion phenotype: implications for the virus replication cycle","volume":"85","author":"Mas","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111043_bib42","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/infdis\/jiz603","article-title":"Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children","volume":"221","author":"McFarland","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2026.111043_bib43","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.virol.2026.111043_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121919","article-title":"Nanoparticle formulation of the fusion protein virus like particles of respiratory syncytial virus stimulates enhanced in vitro antigen presentation and autophagy","volume":"623","author":"Menon","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.virol.2026.111043_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2023.101337","article-title":"Structural basis for respiratory syncytial virus and human metapneumovirus neutralization","volume":"61","author":"Miller","year":"2023","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virol.2026.111043_bib46","doi-asserted-by":"crossref","first-page":"309ra162","DOI":"10.1126\/scitranslmed.aac4241","article-title":"Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera","volume":"7","author":"Ngwuta","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virol.2026.111043_bib47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41541-024-00917-w","article-title":"Author correction: mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice","volume":"9","author":"Ogonczyk-Makowska","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.virol.2026.111043_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011584","article-title":"Structure-based design of a single-chain triple-disulfide-stabilized fusion-glycoprotein trimer that elicits high-titer neutralizing responses against human metapneumovirus","volume":"19","author":"Ou","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2026.111043_bib49","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.vaccine.2020.01.047","article-title":"Evaluation of pre- and post-fusion human metapneumovirus F proteins as subunit vaccine candidates in mice","volume":"38","author":"Pilaev","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.111043_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/v17081140","article-title":"Human metapneumovirus: a narrative review on emerging strategies for prevention and treatment","volume":"17","author":"Principi","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.111043_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2022.07.003","article-title":"Potently neutralizing and protective anti-human metapneumovirus antibodies target diverse sites on the fusion glycoprotein","volume":"55","author":"Rappazzo","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.virol.2026.111043_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111399","article-title":"Characterization of prefusion-F-specific antibodies elicited by natural infection with human metapneumovirus","volume":"40","author":"Rush","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.virol.2026.111043_bib53","doi-asserted-by":"crossref","first-page":"10678","DOI":"10.1128\/JVI.79.16.10678-10689.2005","article-title":"An S101P substitution in the putative cleavage motif of the human metapneumovirus fusion protein is a major determinant for trypsin-independent growth in vero cells and does not alter tissue tropism in hamsters","volume":"79","author":"Schickli","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111043_bib54","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/CMR.00015-11","article-title":"Human metapneumovirus: lessons learned over the first decade","volume":"24","author":"Schildgen","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.virol.2026.111043_bib56","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1128\/JVI.01381-08","article-title":"Low-pH triggering of human metapneumovirus fusion: essential residues and importance in entry","volume":"83","author":"Schowalter","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111043_bib55","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1128\/JVI.01287-06","article-title":"Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH","volume":"80","author":"Schowalter","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111043_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1330209","article-title":"Human metapneumovirus respiratory infection affects both innate and adaptive intestinal immunity","volume":"15","author":"Sepulveda-Alfaro","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2026.111043_bib58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-3-642-23056-1_8","article-title":"Heparin and heparan sulfate: analyzing structure and microheterogeneity","author":"Shriver","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.virol.2026.111043_bib59","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.virol.2005.10.016","article-title":"Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity","volume":"345","author":"Skiadopoulos","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.virol.2026.111043_bib60","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3389\/fimmu.2018.02466","article-title":"Human metapneumovirus: mechanisms and molecular targets used by the virus to avoid the immune system","volume":"9","author":"Soto","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2026.111043_bib61","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3389\/fimmu.2018.02466","article-title":"Human metapneumovirus: mechanisms and molecular targets used by the virus to avoid the immune system","volume":"9","author":"Soto","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2026.111043_bib62","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2106196118","article-title":"Interprotomer disulfide-stabilized variants of the human metapneumovirus fusion glycoprotein induce high titer-neutralizing responses","volume":"118","author":"Stewart-Jones","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.virol.2026.111043_bib63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.virol.2020.01.004","article-title":"SPINT2 inhibits proteases involved in activation of both influenza viruses and metapneumoviruses","volume":"543","author":"Straus","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.virol.2026.111043_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54384-x","article-title":"A potent broad-spectrum neutralizing antibody targeting a conserved region of the prefusion RSV F protein","volume":"15","author":"Sun","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2026.111043_bib65","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/89098","article-title":"A newly discovered human pneumovirus isolated from young children with respiratory tract disease","volume":"7","author":"van den Hoogen","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2026.111043_bib66","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3201\/eid1004.030393","article-title":"Antigenic and genetic variability of human metapneumoviruses","volume":"10","author":"van den Hoogen","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2026.111043_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.962925","article-title":"Role of human metapneumovirus glycoprotein G in modulation of immune responses","volume":"13","author":"Velayutham","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2026.111043_bib68","article-title":"Design and preclinical evaluation of a nanoparticle vaccine against respiratory syncytial virus based on the attachment protein G","volume":"12","author":"Voorzaat","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2026.111043_bib69","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults","volume":"388","author":"Walsh","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2026.111043_bib70","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nsmb.2250","article-title":"Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site","volume":"19","author":"Wen","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virol.2026.111043_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2016.272","article-title":"Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus","volume":"2","author":"Wen","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.virol.2026.111043_bib72","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.chom.2023.07.002","article-title":"Potent cross-neutralization of respiratory syncytial virus and human metapneumovirus through a structurally conserved antibody recognition mode","volume":"31","author":"Wen","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2026.111043_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013312","article-title":"A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus","volume":"21","author":"Young","year":"2025","journal-title":"PLoS Pathog."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226002588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226002588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:58:40Z","timestamp":1788670720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682226002588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":73,"alternative-id":["S0042682226002588"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2026.111043","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing human metapneumovirus vaccine development through fusion protein stabilization","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2026.111043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111043"}}